arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Aditxt, Inc.

ADTX
$0.01 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
22 Metrics
Absolute Benchmarks
Price Chart
18
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Aditxt, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap
Dividend Yield
Revenue Growth -97.6%
Op. Margin
ROIC -275.6%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Jun 24, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.19K
↓ -97.6%
Net Income Profit after all expenses
$-43.10M
↓ -6.8%
FCF / Share Free cash flow per share
$-61.49
↓ -5.4%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Invested CapitalReturn on Invested Capital of -275.6% is weak on an absolute basis (target > 10%)
  • Interest CoverageInterest Coverage of -7.94x is weak on an absolute basis (target > 5x)
  • FCF / Net IncomeFCF / Net Income of 0.60x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health
18
Cash Quality
18

Dividend History

Dividend / share · sourced from SEC filings
$1.52 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters